Florence Nkechi Nworah

Dr. Florence Nkechi Nworah

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2019 in Journal of Environmental Health Science and Engineering
Verified
Journal Article
Closed access
PDF file
FNFlorence Nkechi Nworah
Florence Nkechi Nworah
CNC. C. Nkwocha
C. C. Nkwocha
JNJ. N. Nwachukwu
J. N. Nwachukwu
EEE. C. Ezeako
E. C. Ezeako

22 December 2023 in Engineering Reports
Verified
Journal Article
Open access
VAVictor Onukwube Apeh
Victor Onukwube Apeh
Kennedy Chinedu OkaforKennedy Chinedu Okafor
Kennedy Chinedu Okafor
ICIfeoma Felicia Chukwuma
Ifeoma Felicia Chukwuma
HUHenrietta Onyinye Uzoeto
Henrietta Onyinye Uzoeto
TCTitus Ifeanyi Chinebu
Titus Ifeanyi Chinebu
OAOkoronkwo Chukwunenye Anthony
Okoronkwo Chukwunenye Anthony
The emergence of resistance to current antimalarial drugs poses a significant challenge in the fight against malaria. This study aimed to investigate the in vivo antiplasmodial potential of the aqueous extract of fresh and dried leaves of A3 in Plasmodium berghei‐infected (P. berghei) mice. A 4‐day suppressive test was conducted, with infected BALB/c mice receiving artesunate and A3 extracts. The results showed that the tested doses of A3 attenuated the elevation of parasitemia induced by P. berghei, particularly at the dose of 400 mg/kg, and improved hematological indices. Computational techniques, including molecular docking, binding free energy calculations, and ADMET predictions, identified several bioactive compounds in A3 with promising inhibitory potential against lysyl‐tRNA synthetases and Dihydrofolate reductase (DHFR), the crucial enzymes targeted by antimalarial drugs. In this paper, Friedelin, Bauerenol, Epifriedelanol, Alpha‐Amyrenone, Stigmasterol, and beta‐Amyrin acetate were top‐ranked, having docking scores from −10.6 to −9.9 kcal/mol, compared with the −9.4 and −7.1 kcal/mol demonstrated by artesunate and chloroquine, respectively, as standard ligands. Also, it was shown that docking score from the Lysyl‐tRNA protein target (4YCV) ranged from −9.5 to −7.8 kcal/mol in comparison to artesunate (8.1 kcal/mol) and chloroquine (5.6 kcal/mol). The results suggest that the identified compounds in A3 could serve as potential candidates for the development of new anti‐malarial agents.

23 August 2024 in Heliyon
Verified
Journal Article
Open access
ICIfeoma Chukwuma
Ifeoma Chukwuma
Kennedy Chinedu OkaforKennedy Chinedu Okafor
Kennedy Chinedu Okafor
VAVictor Onukwube Apeh
Victor Onukwube Apeh
FNFlorence Nkechi Nworah
Florence Nkechi Nworah
COChigozie Paul Odo
Chigozie Paul Odo
OAOkoronkwo Chukwunenye Anthony
Okoronkwo Chukwunenye Anthony
The quest for novel antioxidant and anti-inflammatory medications from medicinal plants is crucial since the plants contain bioactive compounds with a better efficacy and safety profile than orthodox therapy. This study harnesses the capabilities of mechatronics-driven Agilent Gas Chromatography, deploying in vitro, in vivo, and in silico models to unravel the antioxidant and anti-inflammatory attributes within Combretum paniculatum ethanol extract (CPEE). Employing gas chromatography-mass spectroscopy (GC-MS), our analysis efficiently segregates and evaluates volatile compound mixtures, a technique renowned for identifying organic compounds, as exemplified by its success in detecting fatty acids in food and resin acids in water. Using gas chromatography-mass spectrometry (GC-MS) and GC-FID analyses, this paper ascertains the comprehensive phytochemical composition of CPEE. Also, Molecular interactions of identified compounds with cyclooxygenase (COX-2) implicated in inflammatory urpsurge is verified. GC-MS and GC-FID analyses unveil 41 phytoconstituents within CPEE. Based on the in vitro research, CPEE demonstrated potential in inhibiting thiobarbituric acid-reactive substances, nitric oxide, and phospholipase lipase A2 with inhibition rates of 2.284, 6.547, and 66.8 μg/mL respectively. In vivo experiments confirm CPEE's efficacy in inhibiting granuloma tissue formation, lipid peroxidation, and neutrophil counts compared to untreated rats. Moreover, CPEE elicited a significant (P < 0.05) increase in the activities of SOD, CAT, and GSH concentrations while decreasing C-reactive protein, signifying promising therapeutic potential. Highlighting interactions between top-scoring phytoligands (epicatechin, catechin, and kaempferol) and COX-2, the findings underscore their drug-like characteristics, favorable pharmacokinetics, and enhanced safety toxicity profiles. Results from in vitro, in vivo, and in silico studies, highlights CPEE remarkable antioxidant and anti-inflammatory potentials.

29 September 2025 in South African Journal of Science
Verified
Journal Article
Open access
FNFlorence Nkechi Nworah
Florence Nkechi Nworah
NINancy C. Igwebuike
Nancy C. Igwebuike
ICIfeoma Chukwuma
Ifeoma Chukwuma
COChigozie P. Odo
Chigozie P. Odo
OEOzoemena Emmanuel Emmanuel Eje
Ozoemena Emmanuel Emmanuel Eje
Nanotechnology has become a focal point of interest on the road to disease intervention due to its vast applications in biomedicine and biotechnology. In this study, we evaluated the antioxidant properties of zinc oxide nanoparticles (ZnONPs) synthesised from Anacardium occidentale leaf extracts. The ZnONPs were characterised using UV-Visible and Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD), scanning electron microscopy with energy dispersive X-ray (SEM-EDX), transmission electron microscopy (TEM) and gas chromatography-flame ionisation detection (GC-FID). Maximum UV-Vis spectra absorption revealed a prominent peak at 364–365 nm. The FTIR showed characteristic peaks at 3202 cm-1, with the O-H functional vibration of carboxylic acids, and 1197 cm-1, confirming the C-O stretch of alcohols. The absorption band of Zn tetrahedral coordination and Zn-O occurred at 869 cm-1 and 731–820 cm-1, respectively. The ZnONPs particle size was 17.19 nm while SEM-EDX revealed the crystalline nature and elemental compositions of the ZnONPs. TEM showed particle size distribution to be within 10–29 nm, while GC-FID revealed the presence of flavonoids, alkaloids and polyphenolic compounds. ZnONPs exhibited high antioxidant properties using 2,2-diphenyl-1-picrylhydrazyl, 2,2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonic, nitric oxide, thiobarbituric acid reactive substances, and ferric reducing antioxidant potential. Our findings show that A. occidentale leaves are a promising source of bioreductants for green synthesis, while the robust antioxidant properties exhibited by the ZnONPs are favourable in biomedical applications.

3 November 2024 in International Journal of Secondary Metabolite
Verified
Journal Article
Open access
PDF file
ICIfeoma Chukwuma
Ifeoma Chukwuma
VAVictor Onukwube Apeh
Victor Onukwube Apeh
FNFlorence Nkechi Nworah
Florence Nkechi Nworah
LELawrence U S Ezeanyika
Lawrence U S Ezeanyika
VOVictor Nwadiogo Ogugua
Victor Nwadiogo Ogugua
MOMARTINS OGUGOFOR
MARTINS OGUGOFOR
A decline in the antioxidant network during the inflammatory response plays a critical role in the pathogenesis of numerous diseases. We designed this study to decipher the therapeutic efficacy of Brenania brieyi in reducing oxidative stress caused by the inflammatory response to cotton pellets. Graded doses of methanol and chloroform fractions of B. brieyi (MFBB and CFBB) and indomethacin were administered to Wistar rats for seven days after implanting sterilised cotton pellets (20 mg). Thereafter, biochemical indices of oxidative stress were determined using blood samples taken through cardiac puncture. Furthermore, molecular interactions, drug-likeness, and toxicity features of B. brieyi phytochemicals were also assessed. Compared with the untreated group, the groups treated with MFBB and CFBB had a significant (p < 0.05) decrease in granuloma tissue weight and MDA levels while increasing glutathione levels, SOD, and CAT activities. In addition, a substantial increase in inflammatory-induced changes in antioxidant nutrients, together with a decline in liver enzymes, was obtained in the treated groups. The docking tests revealed that the top-scoring phytoconstituents of B. brieyi, n-hexadecanoic acid, and 9-octadecanoic acid interacted well with catalase, having docking scores of -6.19 and -7.58 kcal/mol, respectively. Moreover, the hits had good oral drug-likeness features and a safe toxicity profile. The findings of the study provide evidence that B. brieyi has antioxidant and anti-inflammatory properties, suggesting that it could be used as an alternative therapy to regulate oxidative stress-related diseases.

30 September 2021 in Medical Sciences Forum
Verified
Conference Paper
Open access
PDF file
ICIfeoma Chukwuma
Ifeoma Chukwuma
VAVictor Onukwube Apeh
Victor Onukwube Apeh
FNFlorence Nkechi Nworah
Florence Nkechi Nworah
Augustine MaduekeAugustine Madueke
Augustine Madueke
VNValentine Nwanelo
Valentine Nwanelo
The re-emergence of severe acute respiratory syndrome coronavirus 2 A(SARS-CoV-2) in Wuhan, China, has placed an unprecedented economic and health burden globally. The SARS-CoV-2 high mortality rate has brought great challenges to researchers, clinicians, and health workers in their bid to discover appropriate therapeutic interventions. The search for the ultimate remedy was initially centered on the use of antiviral agents targeting receptors and proteins involved in the pathophysiology of SARS-CoV-2. However, the upsurge of interest in repurposing anti-inflammatory agents was born out of the reported risks posed by a cytokine storm on COVID-19-induced fatality. A cytokine storm, as a result of the unregulated production of pro-inflammatory cytokines and other chemical mediators, triggers coagulopathy, viral sepsis, pneumonitis shock, and acute respiratory syndrome, which may lead directly to respiratory and organ failure and ultimately the death of the patient. The overwhelming evidence has shown that the early prediction of cytokine storm using serum chemistry and hematological markers and the use of appropriate anti-inflammatory agents will avert COVID-19 complications. These include the use of repurposed interferon (IFN) therapy and inhibitors of interleukin-1 (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and Janus kinase (JAKs) to nip the cytokine storm in the bud. This review critically used information retrieved from PubMed, China National Knowledge Infrastructure, Embase, Medline, and Google Scholar to elaborate on the mechanism and complications of COVID-19 cytokine storm, therapeutic interventions, and the way forward to discovering effective biocompatible drug targets.